Circadian clock circuitry in colorectal cancer

World Journal of Gastroenterology

Volumn 20, Issue 15, 2014, Pages 4197-4207

  Mazzoccoli, Gianluigi ^a   Vinciguerra, Manlio ^a,b,d   Papa, Gennaro ^c   Piepoli, Ada ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Istituto Euro Mediterraneo di Scienza e Tecnologia (IEMEST)   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Circadian rhythm; Clock gene; Colorectal cancer

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRANSCRIPTION FACTOR CLOCK;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CIRCADIAN RHYTHM; COLORECTAL CANCER; DEACETYLATION; DNA DAMAGE; GENE EXPRESSION; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; UPREGULATION; ANIMAL; CELL TRANSFORMATION; COLORECTAL TUMOR; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE; MALE; METABOLISM; OSCILLOMETRY; PATHOLOGY; PHENOTYPE; RISK FACTOR; TIME;

ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CIRCADIAN CLOCKS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINES; MALE; OSCILLOMETRY; PHENOTYPE; RISK FACTORS; TIME FACTORS;

EID: 84898844306     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i15.4197     Document Type: Article

References (114)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
2. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR and Forman D. Cancer Incidence in Five Continents, Volumes I to IX: IARC CancerBase No. 9 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: URL: http://ci5.iarc.fr
3. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-2460 [PMID: 20018966 DOI: 10.1056/NEJMra0804588]
4. Jensen SA, Vainer B, Kruhøffer M, Sørensen JB. Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression. BMC Cancer 2009; 9: 25 [PMID: 19154585 DOI: 10.1186/1471-2407-9-25]
5. Wright CM, Dent OF, Newland RC, Barker M, Chapuis PH, Bokey EL, Young JP, Leggett BA, Jass JR, Macdonald GA. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma. Gut 2005; 54: 103-108 [PMID: 15591513 DOI: 10.1136/gut.2003.034579]
6. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Colorectal cancer. Lancet 2010; 375: 1030-1047 [PMID: 20304247 DOI: 10.1016/S0140-6736(10)60353-4]
7. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851 [PMID: 10921899 DOI: 10.1101/gad.14.15.1837]
8. Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 2000; 82: 1689-1693 [PMID: 10817505 DOI: 10.1054/bjoc.1999.1112]
9. Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 2012; 74: 246-260 [PMID: 22542179 DOI: 10.1016/j.neuron.2012.04.006]
10. Lemmer B. Discoveries of rhythms in human biological functions: a historical review. Chronobiol Int 2009; 26: 1019-1068 [PMID: 19731105]
11. Bonny O, Vinciguerra M, Gumz ML, Mazzoccoli G. Molecular bases of circadian rhythmicity in renal physiology and pathology. Nephrol Dial Transplant 2013; 28: 2421-2431 [PMID: 23901050 DOI: 10.1093/ndt/gft319]
12. Duguay D, Cermakian N. The crosstalk between physiology and circadian clock proteins. Chronobiol Int 2009; 26: 1479-1513 [PMID: 20030537 DOI: 10.3109/07420520903497575]
13. Lowrey PL, Takahashi JS. Genetics of circadian rhythms in Mammalian model organisms. Adv Genet 2011; 74: 175-230 [PMID: 21924978 DOI: 10.1016/B978-0-12-387690-4.00006-4]
14. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol 2014; 24: 90-99 [PMID: 23916625 DOI: 10.1016/j.tcb.2013.07.002]
15. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 2012; 35: 445-462 [PMID: 22483041 DOI: 10.1146/annurev-neuro-060909-153128]
16. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004; 119: 693-705 [PMID: 15550250 DOI: 10.1016/ j.cell.2004.11.015]
17. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, Lee CC. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001; 105: 683-694 [PMID: 11389837 DOI: 10.1016/S0092-8674(01)00380-4]
18. Smith KD, Fu MA, Brown EJ. Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. J Cell Biol 2009; 187: 15-23 [PMID: 19805627 DOI: 10.1083/jcb.200905006]
19. Kemp MG, Akan Z, Yilmaz S, Grillo M, Smith-Roe SL, Kang TH, Cordeiro-Stone M, Kaufmann WK, Abraham RT, Sancar A, Unsal-Kaçmaz K. Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress. J Biol Chem 2010; 285: 16562-16571 [PMID: 20233725 DOI: 10.1074/jbc.M110.110304]
20. Burris TP. Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. Mol Endocrinol 2008; 22: 1509-1520 [PMID: 18218725 DOI: 10.1210/me.2007-0519]
21. Ripperger JA, Albrecht U. REV-ERB-erating nuclear receptor functions in circadian metabolism and physiology. Cell Res 2012; 22: 1319-1321 [PMID: 22613952 DOI: 10.1038/ cr.2012.81]
22. Yin L, Wu N, Lazar MA. Nuclear receptor Rev-erbalpha: a heme receptor that coordinates circadian rhythm and metabolism. Nucl Recept Signal 2010; 8: e001 [PMID: 20414452 DOI: 10.1621/nrs.08001]
23. Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, Liddle C, Auwerx J, Downes M, Panda S, Evans RM. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature 2012; 485: 123-127 [PMID: 22460952 DOI: 10.1038/nature11048]
24. Uchida Y, Hirayama J, Nishina H. A common origin: signaling similarities in the regulation of the circadian clock and DNA damage responses. Biol Pharm Bull 2010; 33: 535-544 [PMID: 20410582 DOI: 10.1248/bpb.33.535]
25. Sahar S, Zocchi L, Kinoshita C, Borrelli E, Sassone-Corsi P. Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS One 2010; 5: e8561 [PMID: 20049328 DOI: 10.1371/journal. pone.0008561]
26. Kaasik K, Kivimäe S, Allen JJ, Chalkley RJ, Huang Y, Baer K, Kissel H, Burlingame AL, Shokat KM, Ptáček LJ, Fu YH. Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. Cell Metab 2013; 17: 291-302 [PMID: 23395175 DOI: 10.1016/j.cmet.2012.12.017]
27. Li MD, Ruan HB, Hughes ME, Lee JS, Singh JP, Jones SP, Nitabach MN, Yang X. O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1/CLOCK ubiquitination. Cell Metab 2013; 17: 303-310 [PMID: 23395176 DOI: 10.1016/ j.cmet.2012.12.015]
28. Cardone L, Hirayama J, Giordano F, Tamaru T, Palvimo JJ, Sassone-Corsi P. Circadian clock control by SUMOylation of BMAL1. Science 2005; 309: 1390-1394 [PMID: 16109848 DOI: 10.1126/science.1110689]
29. Lee J, Lee Y, Lee MJ, Park E, Kang SH, Chung CH, Lee KH, Kim K. Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol Cell Biol 2008; 28: 6056-6065 [PMID: 18644859 DOI: 10.1128/MCB.00583-08]
30. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008; 134: 329-340 [PMID: 18662547 DOI: 10.1016/j.cell.2008.07.002]
31. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008; 134: 317-328 [PMID: 18662546 DOI: 10.1016/ j.cell.2008.06.050]
32. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCKSIRT1. Science 2009; 324: 654-657 [PMID: 19286518 DOI: 10.1126/science.1170803]
33. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, Imai S, Bass J. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009; 324: 651-654 [PMID: 19299583 DOI: 10.1126/science.1171641]
34. Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 2013; 153: 1448-1460 [PMID: 23791176 DOI: 10.1016/ j.cell.2013.05.027]
35. Bozek K, Relógio A, Kielbasa SM, Heine M, Dame C, Kramer A, Herzel H. Regulation of clock-controlled genes in mammals. PLoS One 2009; 4: e4882 [PMID: 19287494 DOI: 10.1371/ journal.pone.0004882]
36. Hoogerwerf WA. Role of biological rhythms in gastrointestinal health and disease. Rev Endocr Metab Disord 2009; 10: 293-300 [PMID: 19798581 DOI: 10.1007/s11154-009-9119-3]
37. Polidarová L, Soták M, Sládek M, Pacha J, Sumová A. Temporal gradient in the clock gene and cell-cycle checkpoint kinase Wee1 expression along the gut. Chronobiol Int 2009; 26: 607-620 [PMID: 19444744 DOI: 10.1080/07420520902924889]
38. Polidarová L, Sládek M, Soták M, Pácha J, Sumová A. Hepatic, duodenal, and colonic circadian clocks differ in their persistence under conditions of constant light and in their entrainment by restricted feeding. Chronobiol Int 2011; 28: 204-215 [PMID: 21452916 DOI: 10.3109/07420528.2010.54861 5]
39. Mazzoccoli G, Francavilla M, Pazienza V, Benegiamo G, Piepoli A, Vinciguerra M, Giuliani F, Yamamoto T, Takumi T. Differential patterns in the periodicity and dynamics of clock gene expression in mouse liver and stomach. Chronobiol Int 2012; 29: 1300-1311 [PMID: 23131081 DOI: 10.3109/07420528. 2012.728662]
40. Soták M, Polidarová L, Musílková J, Hock M, Sumová A, Pácha J. Circadian regulation of electrolyte absorption in the rat colon. Am J Physiol Gastrointest Liver Physiol 2011; 301: G1066-G1074 [PMID: 21903759 DOI: 10.1152/ajpgi. 00256.2011]
41. Hoogerwerf WA, Shahinian VB, Cornélissen G, Halberg F, Bostwick J, Timm J, Bartell PA, Cassone VM. Rhythmic changes in colonic motility are regulated by period genes. Am J Physiol Gastrointest Liver Physiol 2010; 298: G143-G150 [PMID: 19926812 DOI: 10.1152/ajpgi.00402.2009]
42. Hoogerwerf WA. Role of clock genes in gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol 2010; 299: G549-G555 [PMID: 20558764 DOI: 10.1152/ajpgi.00147.2010]
43. Mazzoccoli G, Palmieri O, Corritore G, Latiano T, Bossa F, Scimeca D, Biscaglia G, Valvano MR, D'Incà R, Cucchiara S, Stronati L, Annese V, Andriulli A, Latiano A. Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease. Chronobiol Int 2012; 29: 994-1003 [PMID: 22881285 DOI: 10.3109/07420528.2012.705935]
44. Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, Piepoli A. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int 2011; 28: 841-851 [PMID: 22080729 DOI: 10.3109/07420528.2011.615182]
45. Mazzoccoli G, Pazienza V, Vinciguerra M. Clock genes and clock-controlled genes in the regulation of metabolic rhythms. Chronobiol Int 2012; 29: 227-251 [PMID: 22390237 DOI: 10.3109/ 07420528.2012.658127]
46. Anderson G, Beischlag TV, Vinciguerra M, Mazzoccoli G. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology. Biochem Pharmacol 2013; 85: 1405-1416 [PMID: 23438471 DOI: 10.1016/j.bcp.2013.02.022]
47. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 255-259 [PMID: 12934012 DOI: 10.1126/science.1086271]
48. Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 2007; 129: 461-464 [PMID: 17482541 DOI: 10.1016/j.cell.2007.04.015]
49. Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, Claustrat B, Hastings MH, Lévi F. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002; 94: 690-697 [PMID: 11983758 DOI: 10.1093/jnci/94.9.690]
50. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50 [PMID: 12372299 DOI: 10.1016/S0092-8674(02)00961-3]
51. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003; 3: 350-361 [PMID: 12724733 DOI: 10.1038/nrc1072]
52. Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006; 17: 525-530 [PMID: 16596306 DOI: 10.1007/s10552-005-9003-8]
53. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 95: 825-828 [PMID: 12783938 DOI: 10.1093/ jnci/95.11.825]
54. Kloog I, Haim A, Stevens RG, Portnov BA. Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int 2009; 26: 108-125 [PMID: 19142761 DOI: 10.1080/07420520802694020]
55. Parent MÉ, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am J Epidemiol 2012; 176: 751-759 [PMID: 23035019 DOI: 10.1093/aje/ kws318]
56. Yang X, Wood PA, Ansell C, Hrushesky WJ. Circadian timedependent tumor suppressor function of period genes. Integr Cancer Ther 2009; 8: 309-316 [PMID: 19926612 DOI: 10.1177/1 534735409352083]
57. Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Peña MM, Hrushesky WJ. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res 2008; 6: 1786-1793 [PMID: 19010825 DOI: 10.1158/1541-7786.MCR-08-0196]
58. Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther 2009; 8: 303-308 [PMID: 20042409 DOI: 10.1177/1534735409355292]
59. Guo B, Chatterjee S, Li L, Kim JM, Lee J, Yechoor VK, Minze LJ, Hsueh W, Ma K. The clock gene, brain and muscle Arntlike 1, regulates adipogenesis via Wnt signaling pathway. FASEB J 2012; 26: 3453-3463 [PMID: 22611086 DOI: 10.1096/ fj.12-205781]
60. Lin F, Chen Y, Li X, Zhao Q, Tan Z. Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochem Funct 2013; 31: 166-172 [PMID: 22961668 DOI: 10.1002/cbf.2871]
61. Yang X, Wood PA, Ansell CM, Ohmori M, Oh EY, Xiong Y, Berger FG, Peña MM, Hrushesky WJ. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem 2009; 145: 289-297 [PMID: 19106159 DOI: 10.1093/jb/mvn167]
62. Yang X, Wood PA, Ansell CM, Quiton DF, Oh EY, Du-Quiton J, Hrushesky WJ. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int 2009; 26: 1323-1339 [PMID: 19916834 DOI: 10.3109/07420520903431301]
63. Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, Xian LJ. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem 2010; 148: 319-326 [PMID: 20576619 DOI: 10.1093/jb/mvq069]
64. Modak C, Chai J. Potential of casein kinase I in digestive cancer screening. World J Gastrointest Oncol 2009; 1: 26-33 [PMID: 21160770 DOI: 10.4251/wjgo.v1.i1.26]
65. Yang WS, Stockwell BR. Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol 2008; 9: R92 [PMID: 18518968 DOI: 10.1186/gb-2008-9-6-r92]
66. Soták M, Polidarová L, Ergang P, Sumová A, Pácha J. An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumors. Int J Cancer 2013; 132: 1032-1041 [PMID: 22865596 DOI: 10.1002/ijc.27760]
67. Mostafaie N, Kállay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W. Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinog 2009; 48: 642-647 [PMID: 19148895 DOI: 10.1002/mc.20510]
68. Krugluger W, Brandstaetter A, Kállay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007; 67: 7917-7922 [PMID: 17699798 DOI: 10.1158/0008-5472.CAN-07-0133]
69. Alhopuro P, Björklund M, Sammalkorpi H, Turunen M, Tuupanen S, Biström M, Niittymäki I, Lehtonen HJ, Kivioja T, Launonen V, Saharinen J, Nousiainen K, Hautaniemi S, Nuorva K, Mecklin JP, Järvinen H, Orntoft T, Arango D, Lehtonen R, Karhu A, Taipale J, Aaltonen LA. Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res 2010; 8: 952-960 [PMID: 20551151 DOI: 10.1158/1541-7786. MCR-10-0086]
70. Wang Y, Hua L, Lu C, Chen Z. Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. World J Surg Oncol 2011; 9: 166 [PMID: 22166120 DOI: 10.1186/1477-7819-9-166]
71. Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun X, Li T, Xing T, Tang H, Peng X, Peng Z. Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol 2012; 19: 3081-3088 [PMID: 22350604 DOI: 10.1245/s10434-012-2279-5]
72. Panza A, Pazienza V, Ripoli M, Benegiamo G, Gentile A, Valvano MR, Augello B, Merla G, Prattichizzo C, Tavano F, Ranieri E, di Sebastiano P, Vinciguerra M, Andriulli A, Mazzoccoli G, Piepoli A. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer. Biochim Biophys Acta 2013; 1833: 1853-1865 [PMID: 23583560 DOI: 10.1016/ j.bbamcr.2013.04.004]
73. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480 [PMID: 17081971 DOI: 10.1016/j.cell.2006.10.018]
74. Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM. Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci USA 2002; 99: 1182-1187 [PMID: 11818547 DOI: 10.1073/pnas.032468199]
75. Lee E, Salic A, Kirschner MW. Physiological regulation of [beta]-catenin stability by Tcf3 and CK1epsilon. J Cell Biol 2001; 154: 983-993 [PMID: 11524435 DOI: 10.1083/jcb.200102074]
76. Schwarz-Romond T, Asbrand C, Bakkers J, Kühl M, Schaeffer HJ, Huelsken J, Behrens J, Hammerschmidt M, Birchmeier W. The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev 2002; 16: 2073-2084 [PMID: 12183362 DOI: 10.1101/ gad.230402]
77. van de Wetering M, de Lau W, Clevers H. WNT signaling and lymphocyte development. Cell 2002; 109 Suppl: S13-S19 [PMID: 11983149 DOI: 10.1016/S0092-8674(02)00709-2]
78. Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, Febbraro A, Parente D, Ambrosino C, Normanno N, Altucci L, Colantuoni V. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome. PLoS One 2010; 5: e14229 [PMID: 21151932 DOI: 10.1371/journal. pone.0014229]
79. Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, Zou B, Gu Q, Wang J, Pang R, Lan HY, Wong BC. Peroxisome proliferatoractivated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res 2009; 69: 4776-4783 [PMID: 19458067 DOI: 10.1158/0008-5472. CAN-08-4754]
80. Pazienza V, Vinciguerra M, Mazzoccoli G. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Res 2012; 2012: 560846 [PMID: 23028383 DOI: 10.1155/2012/560846]
81. Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol 2012; 138: 501-511 [PMID: 22198637 DOI: 10.1007/s00432-011-1126-6]
82. Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, Nozaki A, Numata K, Shiozawa M, Rino Y, Tanaka K, Masuda M, Imada T. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 2011; 25: 1439-1446 [PMID: 21380491 DOI: 10.3892/ or.2011.1207]
83. Talieri M, Papadopoulou S, Scorilas A, Xynopoulos D, Arnogianaki N, Plataniotis G, Yotis J, Agnanti N. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett 2004; 205: 97-106 [PMID: 15036666 DOI: 10.1016/j.canlet.2003.09.033]
84. Troy AM, Sheahan K, Mulcahy HE, Duffy MJ, Hyland JM, O' Donoghue DP. Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression. Eur J Cancer 2004; 40: 1610-1616 [PMID: 15196548 DOI: 10.1016/j.ejca.2004.03.011]
85. Sakakibara T, Hibi K, Koike M, Fujiwara M, Kodera Y, Ito K, Nakao A. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer 2005; 93: 799-803 [PMID: 16091756 DOI: 10.1038/sj.bjc.6602743]
86. Oishi K. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders. Clin Exp Hypertens 2009; 31: 208-219 [PMID: 19387897 DOI: 10.1080/10641960902822468]
87. Oishi K, Miyazaki K, Uchida D, Ohkura N, Wakabayashi M, Doi R, Matsuda J, Ishida N. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice. J Mol Cell Cardiol 2009; 46: 545-552 [PMID: 19168071 DOI: 10.1016/ j.yjmcc.2009.01.001]
88. Schoenhard JA, Eren M, Johnson CH, Vaughan DE. Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization. Am J Physiol Cell Physiol 2002; 283: C103-C114 [PMID: 12055078 DOI: 10.1152/ajpcell. 00541.2001]
89. Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol 2003; 35: 473-481 [PMID: 12738229 DOI: 10.1016/S0022-2828(03)00051-8]
90. Sasaki M, Yoshitane H, Du NH, Okano T, Fukada Y. Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription. J Biol Chem 2009; 284: 25149-25159 [PMID: 19605937 DOI: 10.1074/jbc.M109.040758]
91. Pazienza V, Piepoli A, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Mazzoccoli G. SIRT1 and the clock gene machinery in colorectal cancer. Cancer Invest 2012; 30: 98-105 [PMID: 22149272 DOI: 10.3109/07357907.2011.640 650]
92. Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 2009; 284: 18210-18217 [PMID: 19433578 DOI: 10.1074/jbc.M109.000034]
93. Antoch MP, Kondratov RV, Takahashi JS. Circadian clock genes as modulators of sensitivity to genotoxic stress. Cell Cycle 2005; 4: 901-907 [PMID: 15917646 DOI: 10.4161/cc.4.7.1792]
94. Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 2007; 17: 311-317 [PMID: 17644383 DOI: 10.1016/ j.tcb.2007.07.001]
95. Antoch MP, Kondratov RV. Circadian proteins and genotoxic stress response. Circ Res 2010; 106: 68-78 [PMID: 20056947 DOI: 10.1161/CIRCRESAHA.109.207076]
96. Murakami Y, Higashi Y, Matsunaga N, Koyanagi S, Ohdo S. Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology 2008; 135: 1636-1644. e3 [PMID: 18773899 DOI: 10.1053/ j.gastro.2008.07.073]
97. Brandi G, Calabrese C, Pantaleo MA, Morselli Labate A, Di Febo G, Hakim R, De Vivo A, Di Marco MC, Biasco G. Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. Cancer Lett 2004; 208: 193-196 [PMID: 15142678 DOI: 10.1016/j.canlet.2003.11.015]
98. Lévi F, Focan C, Karaboué A, de la Valette V, Focan-Henrard D, Baron B, Kreutz F, Giacchetti S. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv Drug Deliv Rev 2007; 59: 1015-1035 [PMID: 17692427 DOI: 10.1016/j.addr.2006.11.001]
99. Hrushesky WJ, Grutsch J, Wood P, Yang X, Oh EY, Ansell C, Kidder S, Ferrans C, Quiton DF, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 2009; 8: 387-397 [PMID: 19926611 DOI: 10.1177/1534735409352086]
100. Antoch MP, Kondratov RV. Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapy. Handb Exp Pharmacol 2013; (217): 289-309 [PMID: 23604484 DOI: 10.1007/978-3-642-259 50-0_12]
101. Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 2007; 47: 593-628 [PMID: 17209800 DOI: 10.1146/annurev.pharmtox. 47.120505.105208]
102. Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, Smaaland R, Focan C, Coudert B, Humblet Y, Canon JL, Adenis A, Lo Re G, Carvalho C, Schueller J, Anciaux N, Lentz MA, Baron B, Gorlia T, Lévi F. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol 2006; 24: 3562-3569 [PMID: 16877722 DOI: 10.1200/JCO.2006.06.1440]
103. Bur IM, Cohen-Solal AM, Carmignac D, Abecassis PY, Chauvet N, Martin AO, van der Horst GT, Robinson IC, Maurel P, Mollard P, Bonnefont X. The circadian clock components CRY1 and CRY2 are necessary to sustain sex dimorphism in mouse liver metabolism. J Biol Chem 2009; 284: 9066-9073 [PMID: 19211562 DOI: 10.1074/jbc.M808360200]
104. Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, Liu R, Huang W. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One 2013; 8: e61679 [PMID: 23626715 DOI: 10.1371/journal.pone.0061679]
105. Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem 2010; 285: 3030-3034 [PMID: 19996108 DOI: 10.1074/jbc.M109.050237]
106. Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol 2009; 27: 1814-1821 [PMID: 19273709 DOI: 10.1200/JCO.2008.18.2071]
107. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005; 102: 3407-3412 [PMID: 15689397 DOI: 10.1073/pnas.0409897102]
108. Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Stravopodis DJ, Bramis K, Lymperi M, Pektasidis D. Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol 2013; 108: 563-567 [PMID: 24037774 DOI: 10.1002/jso.23434]
109. Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Lymberi M, Pektasides D. Expression of clock genes in patients with colorectal cancer. Int J Biol Markers 2013; 28: 280-285 [PMID: 23712462 DOI: 10.5301/jbm.5000033]
110. Wang L, Chen B, Wang Y, Sun N, Lu C, Qian R, Hua L. hClock gene expression in human colorectal carcinoma. Mol Med Rep 2013; 8: 1017-1022 [PMID: 23970287 DOI: 10.3892/ mmr.2013.1643]
111. Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Martínez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, Cuttitta F. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 2008; 118: 640-650 [PMID: 18172554 DOI: 4207 April 21, 2014{pipe}Volume 20{pipe}WJG{pipe}www.wjgnet.com Issue 15{pipe} 10.1172/JCI30024]
112. Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta 2013; 1836: 197-210 [PMID: 23711559 DOI: 10.1016/j.bbcan.2013.05.001]
113. Niestroy J, Barbara A, Herbst K, Rode S, van Liempt M, Roos PH. Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro 2011; 25: 671-683 [PMID: 21256954 DOI: 10.1016/j.tiv.2011.01.008]
114. Xie G, Peng Z, Raufman JP. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1006-G1015 [PMID: 22361730 DOI: 10.1152/ajpgi.00427.2011]